<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Extraction extraction-result-74 - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Extracted Data Details for extraction-result-74</h1>

        <div class="section">
            <h2>Extracted Data (Header)</h2>
            <div class="info-section">
                <p><strong>Extraction ID:</strong> extraction-result-74</p>
                <p><strong>Extraction Schema Used (ID):</strong> <a href="../schemas/extraction-schema-4.html">extraction-schema-4</a></p>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of factors that explain why some smokers develop lung cancer while others do not, including genetic factors, exposure characteristics, environmental co-factors, protective factors, and mechanistic explanations for differential susceptibility.</div>
                <p><strong>Paper ID:</strong> paper-aa0a27f11932f91f89bcb8e59356f18c8255774d</p>
                <p><strong>Paper Title:</strong> <a href="https://www.semanticscholar.org/paper/aa0a27f11932f91f89bcb8e59356f18c8255774d" target="_blank">Genetic variability in DNA repair and cell cycle control pathway genes and risk of smoking‐related lung cancer</a></p>
                <p><strong>Paper Venue:</strong> Molecular Carcinogenesis</p>
                <p><strong>Paper TL;DR:</strong> The data suggests that variation in DNA repair and cell cycle control pathway genes is associated with smoking‐related lung cancer risk and combining genotype information for SNPs in these pathways may assist in classifying current and ex‐cigarette smokers according to Lung cancer risk.</p>
                <p><strong>Cost:</strong> 0.023</p>
            </div>
        </div>

        <div class="section">
            <h2>Extracted Data (Details)</h2>
            <div class="extraction-instance-container" id="e74.0">
                <h3 class="extraction-instance">Extracted Data Instance 0 (e74.0)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of factors that explain why some smokers develop lung cancer while others do not, including genetic factors, exposure characteristics, environmental co-factors, protective factors, and mechanistic explanations for differential susceptibility.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>DNA_repair_variation</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Variation in DNA repair pathway genes (NER, BER)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Common genetic variation in nucleotide excision repair (NER) and base excision repair (BER) pathway genes is associated with differential risk of smoking-related lung cancer, with multiple single-nucleotide polymorphisms and haplotypes showing increased or decreased odds ratios in a case-control study of smokers.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Genetic variability in DNA repair and cell cycle control pathway genes and risk of smoking-related lung cancer</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>study_type</strong></td>
                            <td>case-control study</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>White current and ex-cigarette smokers enrolled at University of Pittsburgh: 722 lung cancer cases and 929 controls (white genetic ancestry cluster), age range 45–85, all with ≥10 pack-year cumulative cigarette exposure</td>
                        </tr>
                        <tr>
                            <td><strong>genetic_factor</strong></td>
                            <td>Multiple NER and BER genes and SNPs, including (example list) ERCC1 (rs3212955), ERCC2 (rs238405), ERCC5 (rs4150351), GTF2H4 (rs2074508), LIG1 (rs10500298), RPA1/2/3 (multiple SNPs), PARP1 (rs747658, rs3219073, rs3219090, rs2048424, rs2666428, rs8679), XRCC1 (rs1799782/Arg194Trp, rs3213255, rs3213266, rs762507) and others.</td>
                        </tr>
                        <tr>
                            <td><strong>genetic_factor_description</strong></td>
                            <td>Variants occur in genes mediating NER (repairs bulky DNA adducts such as benzo(a)pyrene adducts), BER (repairs oxidative DNA damage from cigarette smoke), and associated scaffold or replication proteins; functional variation can alter DNA damage recognition, excision, repair coordination, or recruitment of repair complexes.</td>
                        </tr>
                        <tr>
                            <td><strong>genetic_risk_estimate</strong></td>
                            <td>Multiple SNP-specific estimates reported; representative adjusted ORs include PARP1 rs747658 OR=0.62 (95% CI 0.49–0.78), PARP1 rs3219073 OR=0.61 (95% CI 0.48–0.77), GTF2H4 rs2074508 OR=0.73 (95% CI 0.59–0.90), LIG1 rs10500298 (recessive) OR=1.73 (95% CI 1.29–2.32), XRCC1 rs1799782 OR=0.53 (95% CI 0.34–0.84), XRCC1 rs3213255 OR=1.52 (95% CI 1.14–2.01); also multi-SNP genotype risk summary score quartile ORs: Q3 OR=2.21 (95% CI 1.66–2.95), Q4 OR=3.44 (95% CI 2.58–4.59).</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_exposure_measure</strong></td>
                            <td>Cumulative exposure measured as pack-years; categorized (<35, 35–49, 50–74, 75+).</td>
                        </tr>
                        <tr>
                            <td><strong>dose_response_relationship</strong></td>
                            <td>No formal continuous dose-response model presented here; cases had higher representation in the largest pack-year category (75+) than controls, suggesting increased risk with greater pack-years, but no quantitative slope reported.</td>
                        </tr>
                        <tr>
                            <td><strong>percentage_smokers_develop_cancer</strong></td>
                            <td>Paper states 'fewer than one of five smokers develop lung cancer' (i.e., <20%); no new study-specific lifetime percentage calculated.</td>
                        </tr>
                        <tr>
                            <td><strong>metabolic_factor</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>dna_repair_factor</strong></td>
                            <td>Yes — deficiencies or functional variation in NER (repairs bulky adducts such as benzo(a)pyrene), BER (repairs reactive oxygen species–induced damage), and double-strand break repair coordination implied by variation in repair scaffold and ligase genes (e.g., XRCC1, PARP1, LIG1, ERCC family) are implicated in differential susceptibility.</td>
                        </tr>
                        <tr>
                            <td><strong>immune_inflammatory_factor</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>environmental_cofactor</strong></td>
                            <td>Primary environmental co-factor evaluated: cigarette smoking (pack-years). The paper notes genetic effects may be detectable only in presence of DNA-damaging environmental exposures such as cigarette smoke; no other specific environmental co-exposures (asbestos, radon, pollution) were evaluated in this study.</td>
                        </tr>
                        <tr>
                            <td><strong>protective_factor</strong></td>
                            <td>Specific minor alleles and haplotypes in repair genes associated with reduced lung cancer risk (e.g., PARP1 haplotypes containing rs747658/rs3219073 minor alleles; GTF2H4 haplotype containing rs2074508 minor allele; XRCC1 haplotypes containing rs1799782 Trp194).</td>
                        </tr>
                        <tr>
                            <td><strong>protective_factor_effect</strong></td>
                            <td>Example protective effect sizes: PARP1 rs747658 adjusted OR=0.62 (95% CI 0.49–0.78); PARP1 rs3219073 adjusted OR=0.61 (95% CI 0.48–0.77); GTF2H4 rs2074508 adjusted OR=0.73 (95% CI 0.59–0.90); XRCC1 rs1799782 adjusted OR=0.53 (95% CI 0.34–0.84).</td>
                        </tr>
                        <tr>
                            <td><strong>mechanistic_explanation</strong></td>
                            <td>Inter-individual differences in DNA repair capacity and cell-cycle checkpoint function modulate accumulation and fixation of tobacco-induced DNA lesions: NER removes bulky adducts (e.g., benzo(a)pyrene adducts), BER repairs oxidative lesions from smoking-generated reactive oxygen species, PARP1 detects single-strand breaks and recruits XRCC1 to initiate BER, DNA ligase I (LIG1) completes repair; variation that reduces repair efficiency or alters damage signaling permits persistence of mutations and tumorigenesis, whereas alleles that enhance repair or proper checkpoint-mediated apoptosis reduce risk. Additionally, cell-cycle control variation (p53, p21, cyclins) can modulate whether damaged cells are arrested/apoptosed or allowed to proliferate, amplifying effects of repair deficiencies.</td>
                        </tr>
                        <tr>
                            <td><strong>cancer_subtype</strong></td>
                            <td>Non-small cell lung cancer subtypes emphasized (adenocarcinoma and squamous cell carcinoma); some SNPs showed subtype frequency differences (e.g., LIG1 rs10500298 more common in adenocarcinoma vs squamous; PARP1 rs2048424 minor allele homozygotes more common in adenocarcinomas).</td>
                        </tr>
                        <tr>
                            <td><strong>interaction_effects</strong></td>
                            <td>Limited evidence of gene-environment interaction in this study; one SNP (RPA3 rs7783714) showed sex-specific association (reduced risk among women: OR=0.41, 95% CI 0.23–0.74; P_interaction=0.04). Analyses stratified by pack-year, age, enrollment year did not identify other meaningful effect modification; paper notes that genetic effects may manifest primarily in presence of smoking.</td>
                        </tr>
                        <tr>
                            <td><strong>key_finding</strong></td>
                            <td>Common variation across multiple DNA repair and cell-cycle genes (NER and BER pathways and repair scaffolds) is associated with altered risk of smoking-related lung cancer, with some alleles/haplotypes conferring protection and others conferring increased risk; combining multi-SNP information (31-SNP summary score) stratified smokers across a >3-fold risk range.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Genetic variability in DNA repair and cell cycle control pathway genes and risk of smoking‐related lung cancer', 'publication_date_yy_mm': '2012-10'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e74.1">
                <h3 class="extraction-instance">Extracted Data Instance 1 (e74.1)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of factors that explain why some smokers develop lung cancer while others do not, including genetic factors, exposure characteristics, environmental co-factors, protective factors, and mechanistic explanations for differential susceptibility.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>PARP1</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Poly(ADP-ribose) polymerase 1 (PARP1) genetic variation</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Common PARP1 SNPs and haplotypes were significantly associated with lung cancer risk in smokers; certain minor alleles/haplotypes conferred reduced risk and PARP1's biochemical role in single-strand break sensing and BER provides a mechanism.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Genetic variability in DNA repair and cell cycle control pathway genes and risk of smoking-related lung cancer</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>study_type</strong></td>
                            <td>case-control study</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>White current and ex-cigarette smokers: 722 cases and 929 controls, ages 45–85, ≥10 pack-years.</td>
                        </tr>
                        <tr>
                            <td><strong>genetic_factor</strong></td>
                            <td>PARP1 SNPs: rs747658, rs3219073, rs3219090, rs2048424, rs2666428, rs8679, rs1136410 (Val762Ala was genotyped but not significantly associated in this study).</td>
                        </tr>
                        <tr>
                            <td><strong>genetic_factor_description</strong></td>
                            <td>PARP1 binds to DNA strand breaks, synthesizes poly(ADP-ribose) chains on nuclear proteins, recruits XRCC1, and initiates BER; functional variants can change enzymatic activity and thereby modulate BER efficiency.</td>
                        </tr>
                        <tr>
                            <td><strong>genetic_risk_estimate</strong></td>
                            <td>Adjusted ORs: rs747658 OR=0.62 (95% CI 0.49–0.78, P=5.8×10⁻⁵); rs3219073 OR=0.61 (95% CI 0.48–0.77, P=4.6×10⁻⁵); rs3219090 adjusted OR=0.64 (95% CI 0.43–0.95, P=0.027); rs2666428 adjusted OR=0.64 (95% CI 0.43–0.95, P=0.027).</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_exposure_measure</strong></td>
                            <td>Pack-years (categorized).</td>
                        </tr>
                        <tr>
                            <td><strong>dose_response_relationship</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>percentage_smokers_develop_cancer</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>metabolic_factor</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>dna_repair_factor</strong></td>
                            <td>Direct — PARP1 is a key BER enzyme/coordinator; variation likely affects BER initiation and single-strand break processing.</td>
                        </tr>
                        <tr>
                            <td><strong>immune_inflammatory_factor</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>environmental_cofactor</strong></td>
                            <td>Effect is interpreted in context of cigarette-smoke–induced DNA damage; no other co-exposures studied.</td>
                        </tr>
                        <tr>
                            <td><strong>protective_factor</strong></td>
                            <td>Minor alleles of rs747658 and rs3219073, and PARP1 haplotypes containing these minor alleles, associated with reduced lung cancer risk.</td>
                        </tr>
                        <tr>
                            <td><strong>protective_factor_effect</strong></td>
                            <td>Adjusted OR ~0.61–0.62 per minor allele for rs3219073/rs747658 (≈38–39% risk reduction per allele in this population).</td>
                        </tr>
                        <tr>
                            <td><strong>mechanistic_explanation</strong></td>
                            <td>Reduced or altered PARP1 function can change BER efficiency and downstream repair coordination with XRCC1; specific functional PARP1 variants have been reported (elsewhere) to reduce enzymatic activity (e.g., Val762Ala), which may increase risk in some populations, whereas other variant combinations/haplotypes may be protective — indicating complex functional consequences of PARP1 variation on repair of smoking-induced DNA damage.</td>
                        </tr>
                        <tr>
                            <td><strong>cancer_subtype</strong></td>
                            <td>Associations observed in overall lung cancer cases; one PARP1 SNP (rs2048424) had different homozygote frequencies between adenocarcinoma and squamous cell carcinoma cases.</td>
                        </tr>
                        <tr>
                            <td><strong>interaction_effects</strong></td>
                            <td>No robust gene-environment interactions apart from subtype frequency differences; PARP1 rs2048424 homozygotes more common in adenocarcinomas than squamous (P=0.049).</td>
                        </tr>
                        <tr>
                            <td><strong>key_finding</strong></td>
                            <td>PARP1 genetic variation (notably rs747658 and rs3219073) is strongly associated with reduced risk of smoking-related lung cancer in this white smoker population, consistent with PARP1's central role in BER.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Genetic variability in DNA repair and cell cycle control pathway genes and risk of smoking‐related lung cancer', 'publication_date_yy_mm': '2012-10'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e74.2">
                <h3 class="extraction-instance">Extracted Data Instance 2 (e74.2)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of factors that explain why some smokers develop lung cancer while others do not, including genetic factors, exposure characteristics, environmental co-factors, protective factors, and mechanistic explanations for differential susceptibility.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>XRCC1</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>X-ray repair cross-complementing protein 1 (XRCC1) variation</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>XRCC1 SNPs and haplotypes were associated with both decreased and increased lung cancer risk in smokers; XRCC1 functions as a scaffold in BER interacting with PARP1 and other repair proteins.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Genetic variability in DNA repair and cell cycle control pathway genes and risk of smoking-related lung cancer</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>study_type</strong></td>
                            <td>case-control study</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>White current and ex-cigarette smokers, 722 cases and 929 controls, ages 45–85, ≥10 pack-years.</td>
                        </tr>
                        <tr>
                            <td><strong>genetic_factor</strong></td>
                            <td>XRCC1 SNPs: rs1799782 (Arg194Trp), rs3213255, rs3213266, rs762507, and XRCC1 haplotypes.</td>
                        </tr>
                        <tr>
                            <td><strong>genetic_factor_description</strong></td>
                            <td>XRCC1 is a scaffold protein coordinating BER through interactions with PARP1, LIG3, POLB, APEX1 and PNKP; coding variants may affect repair complex assembly and single-strand break resolution.</td>
                        </tr>
                        <tr>
                            <td><strong>genetic_risk_estimate</strong></td>
                            <td>Adjusted ORs: rs1799782 (Trp194) dominant model OR=0.53 (95% CI 0.34–0.84, P=0.006) indicating reduced risk; rs3213255 (recessive model) adjusted OR=1.52 (95% CI 1.14–2.01, P=0.004) indicating increased risk; haplotypes including rs1799782 associated with reduced risk (example haplotype OR=0.47, 95% CI 0.31–0.70).</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_exposure_measure</strong></td>
                            <td>Pack-years (categorized); paper notes Trp194 protective effect may be limited to heavy smokers in other studies.</td>
                        </tr>
                        <tr>
                            <td><strong>dose_response_relationship</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>percentage_smokers_develop_cancer</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>metabolic_factor</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>dna_repair_factor</strong></td>
                            <td>Yes — XRCC1 variation likely affects BER scaffold formation and efficiency of single-strand break repair, influencing mutation fixation from smoking-induced lesions.</td>
                        </tr>
                        <tr>
                            <td><strong>immune_inflammatory_factor</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>environmental_cofactor</strong></td>
                            <td>Effects interpreted in context of cigarette smoke–induced oxidative DNA damage; prior literature suggests Trp194 effect may be observed mainly in heavy smokers.</td>
                        </tr>
                        <tr>
                            <td><strong>protective_factor</strong></td>
                            <td>XRCC1 Trp194 (rs1799782) associated with reduced lung cancer risk in this smoker population.</td>
                        </tr>
                        <tr>
                            <td><strong>protective_factor_effect</strong></td>
                            <td>Adjusted OR=0.53 (95% CI 0.34–0.84) under dominant model.</td>
                        </tr>
                        <tr>
                            <td><strong>mechanistic_explanation</strong></td>
                            <td>XRCC1 acts as BER scaffold; allelic variation (e.g., Trp194) may alter protein interactions or stability, changing BER efficiency and thereby modifying the probability that smoking-induced single-strand lesions progress to permanent mutations and cancer.</td>
                        </tr>
                        <tr>
                            <td><strong>cancer_subtype</strong></td>
                            <td>Associations reported for overall lung cancer; haplotype associations observed but subtype-specific differences not emphasized for XRCC1 beyond haplotype effects.</td>
                        </tr>
                        <tr>
                            <td><strong>interaction_effects</strong></td>
                            <td>Paper cites other studies where XRCC1 Trp194 protective effect appeared in heavy smokers; this study did not detect strong pack-year interactions for these SNPs beyond that contextual note.</td>
                        </tr>
                        <tr>
                            <td><strong>key_finding</strong></td>
                            <td>XRCC1 common variants (including Arg194Trp) are associated with altered susceptibility to smoking-related lung cancer, supporting a role for BER scaffold efficiency in differential cancer risk among smokers.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Genetic variability in DNA repair and cell cycle control pathway genes and risk of smoking‐related lung cancer', 'publication_date_yy_mm': '2012-10'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e74.3">
                <h3 class="extraction-instance">Extracted Data Instance 3 (e74.3)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of factors that explain why some smokers develop lung cancer while others do not, including genetic factors, exposure characteristics, environmental co-factors, protective factors, and mechanistic explanations for differential susceptibility.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>GTF2H4</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>GTF2H4 (p52 subunit of TFIIH) variation</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>A SNP in GTF2H4 (rs2074508) and a GTF2H4 haplotype were associated with reduced lung cancer risk; GTF2H4 encodes the p52 subunit of TFIIH involved in DNA opening during NER.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Genetic variability in DNA repair and cell cycle control pathway genes and risk of smoking-related lung cancer</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>study_type</strong></td>
                            <td>case-control study</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>White current and ex-cigarette smokers: 722 cases and 929 controls, ages 45–85, ≥10 pack-years.</td>
                        </tr>
                        <tr>
                            <td><strong>genetic_factor</strong></td>
                            <td>GTF2H4 rs2074508 and GTF2H4 haplotypes.</td>
                        </tr>
                        <tr>
                            <td><strong>genetic_factor_description</strong></td>
                            <td>GTF2H4 encodes TFIIH p52 subunit which may regulate ATPase/helicase activity of TFIIH (XPB/ERCC3) to open DNA at sites of helix-distorting damage during NER; variation could influence NER efficiency.</td>
                        </tr>
                        <tr>
                            <td><strong>genetic_risk_estimate</strong></td>
                            <td>Adjusted OR for rs2074508 (additive) = 0.73 (95% CI 0.59–0.90, P=0.003); GTF2H4 haplotype OR=0.70 (95% CI 0.58–0.85, P=4.0×10⁻⁴).</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_exposure_measure</strong></td>
                            <td>Pack-years categorized.</td>
                        </tr>
                        <tr>
                            <td><strong>dose_response_relationship</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>percentage_smokers_develop_cancer</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>metabolic_factor</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>dna_repair_factor</strong></td>
                            <td>NER — variation in a TFIIH subunit may affect NER opening of DNA at bulky adducts (e.g., PAH adducts from tobacco smoke).</td>
                        </tr>
                        <tr>
                            <td><strong>immune_inflammatory_factor</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>environmental_cofactor</strong></td>
                            <td>Effect considered in context of tobacco carcinogen exposure (benzo(a)pyrene produces NER substrates).</td>
                        </tr>
                        <tr>
                            <td><strong>protective_factor</strong></td>
                            <td>rs2074508 minor allele and associated haplotype linked to reduced lung cancer risk.</td>
                        </tr>
                        <tr>
                            <td><strong>protective_factor_effect</strong></td>
                            <td>Adjusted OR=0.73 (95% CI 0.59–0.90) for rs2074508; haplotype adjusted OR=0.70 (95% CI 0.58–0.85).</td>
                        </tr>
                        <tr>
                            <td><strong>mechanistic_explanation</strong></td>
                            <td>Reduced or altered TFIIH subunit function changes DNA opening and lesion verification during NER, modulating repair of tobacco-induced bulky adducts and thereby affecting fixation of mutations.</td>
                        </tr>
                        <tr>
                            <td><strong>cancer_subtype</strong></td>
                            <td>Overall lung cancer (no strong subtype-only effect reported for this SNP).</td>
                        </tr>
                        <tr>
                            <td><strong>interaction_effects</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>key_finding</strong></td>
                            <td>Variation in GTF2H4 (TFIIH p52) is associated with decreased smoking-related lung cancer risk, pointing to NER efficiency as a determinant of differential susceptibility.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Genetic variability in DNA repair and cell cycle control pathway genes and risk of smoking‐related lung cancer', 'publication_date_yy_mm': '2012-10'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e74.4">
                <h3 class="extraction-instance">Extracted Data Instance 4 (e74.4)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of factors that explain why some smokers develop lung cancer while others do not, including genetic factors, exposure characteristics, environmental co-factors, protective factors, and mechanistic explanations for differential susceptibility.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>LIG1</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>DNA ligase I (LIG1) variation</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>A recessive LIG1 variant (rs10500298) was associated with increased lung cancer risk and was more frequent among adenocarcinoma cases than squamous cell carcinoma cases.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Genetic variability in DNA repair and cell cycle control pathway genes and risk of smoking-related lung cancer</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>study_type</strong></td>
                            <td>case-control study</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>White current and ex-cigarette smokers: 722 cases and 929 controls, ages 45–85, ≥10 pack-years.</td>
                        </tr>
                        <tr>
                            <td><strong>genetic_factor</strong></td>
                            <td>LIG1 rs10500298 (and 21 LIG1 SNPs examined).</td>
                        </tr>
                        <tr>
                            <td><strong>genetic_factor_description</strong></td>
                            <td>DNA ligase I joins Okazaki fragments during replication and completes ligation steps in BER and NER; variation may reduce ligation and completion of repair.</td>
                        </tr>
                        <tr>
                            <td><strong>genetic_risk_estimate</strong></td>
                            <td>Adjusted recessive model OR=1.73 (95% CI 1.29–2.32, P=2.7×10⁻⁴); unadjusted OR for homozygotes reported as 1.96 (95% CI 1.52–2.53). More frequent among adenocarcinoma cases (28.0%) than squamous cases (19.9%).</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_exposure_measure</strong></td>
                            <td>Pack-years (categorized).</td>
                        </tr>
                        <tr>
                            <td><strong>dose_response_relationship</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>percentage_smokers_develop_cancer</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>metabolic_factor</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>dna_repair_factor</strong></td>
                            <td>Yes — LIG1 completes BER/NER ligation; deficient ligation could leave repair incomplete, increasing mutagenesis.</td>
                        </tr>
                        <tr>
                            <td><strong>immune_inflammatory_factor</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>environmental_cofactor</strong></td>
                            <td>Context of tobacco-induced DNA damage; no other co-exposures evaluated.</td>
                        </tr>
                        <tr>
                            <td><strong>protective_factor</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>protective_factor_effect</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>mechanistic_explanation</strong></td>
                            <td>Impaired ligase activity could result in incomplete repair of single-strand breaks or gaps, increasing the chance of mutation fixation from tobacco-induced DNA damage and promoting carcinogenesis, possibly with tissue/subtype specificity as suggested by adenocarcinoma enrichment.</td>
                        </tr>
                        <tr>
                            <td><strong>cancer_subtype</strong></td>
                            <td>Observed higher frequency of risk genotype among adenocarcinoma cases vs squamous cell carcinoma cases.</td>
                        </tr>
                        <tr>
                            <td><strong>interaction_effects</strong></td>
                            <td>Subtype association (adenocarcinoma > squamous) for LIG1 rs10500298 homozygotes (P=0.027).</td>
                        </tr>
                        <tr>
                            <td><strong>key_finding</strong></td>
                            <td>A recessive LIG1 variant (rs10500298) confers increased risk of smoking-related lung cancer, supporting the importance of ligation completion in repair of tobacco-induced DNA damage.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Genetic variability in DNA repair and cell cycle control pathway genes and risk of smoking‐related lung cancer', 'publication_date_yy_mm': '2012-10'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e74.5">
                <h3 class="extraction-instance">Extracted Data Instance 5 (e74.5)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of factors that explain why some smokers develop lung cancer while others do not, including genetic factors, exposure characteristics, environmental co-factors, protective factors, and mechanistic explanations for differential susceptibility.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Genotype_risk_summary</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>31-SNP genotype risk summary score</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>A composite genotype score summing risk contributions from 31 SNPs across 15 genes stratified smokers into quartiles with markedly different lung cancer odds, illustrating cumulative genetic susceptibility.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Genetic variability in DNA repair and cell cycle control pathway genes and risk of smoking-related lung cancer</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>study_type</strong></td>
                            <td>case-control study (multi-SNP risk modeling)</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>White current and ex-cigarette smokers: 722 cases and 929 controls, ages 45–85, ≥10 pack-years.</td>
                        </tr>
                        <tr>
                            <td><strong>genetic_factor</strong></td>
                            <td>31 SNPs included from NER (20 SNPs), BER (7 SNPs) and cell cycle control (4 SNPs); examples: ERCC1 rs3212955, GTF2H4 rs2074508, LIG1 rs10500298, PARP1 rs3219073, XRCC1 rs1799782, CCND1 rs3918298, CDKN2A rs11515.</td>
                        </tr>
                        <tr>
                            <td><strong>genetic_factor_description</strong></td>
                            <td>Aggregates individual SNP effects (scored by best genetic model and direction of allele effect) to produce a continuous summary score reflecting cumulative genetic predisposition related to DNA repair and cell-cycle pathways.</td>
                        </tr>
                        <tr>
                            <td><strong>genetic_risk_estimate</strong></td>
                            <td>Compared to lowest quartile, adjusted ORs: Q2 OR=0.96 (95% CI 0.65–1.41), Q3 OR=2.21 (95% CI 1.57–3.10), Q4 OR=3.12 (95% CI 2.23–4.38); unadjusted Q4 OR=3.44 (95% CI 2.58–4.59). ROC AUC for summary score = 0.636.</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_exposure_measure</strong></td>
                            <td>Pack-years (categorized) used as covariate in adjusted models.</td>
                        </tr>
                        <tr>
                            <td><strong>dose_response_relationship</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>percentage_smokers_develop_cancer</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>metabolic_factor</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>dna_repair_factor</strong></td>
                            <td>Composite captures variation in DNA repair and cell-cycle genes implicated in BER and NER pathways.</td>
                        </tr>
                        <tr>
                            <td><strong>immune_inflammatory_factor</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>environmental_cofactor</strong></td>
                            <td>Constructed and analyzed in a population of smokers; score performance and interpretation are conditional on smoking exposure.</td>
                        </tr>
                        <tr>
                            <td><strong>protective_factor</strong></td>
                            <td>Lower summary scores represent net-protective genotype combinations.</td>
                        </tr>
                        <tr>
                            <td><strong>protective_factor_effect</strong></td>
                            <td>Lowest quartile = reference; 3rd and 4th quartiles had ~2.2- to 3.4-fold increased risk relative to first quartile (see genetic_risk_estimate).</td>
                        </tr>
                        <tr>
                            <td><strong>mechanistic_explanation</strong></td>
                            <td>Cumulative burden of functional variants across multiple DNA repair and cell-cycle genes compounds effects on repair proficiency and damage response, producing larger net differences in cancer susceptibility than single variants.</td>
                        </tr>
                        <tr>
                            <td><strong>cancer_subtype</strong></td>
                            <td>Score derived on overall lung cancer cases (smokers); subtype-specific performance not detailed beyond case-case comparisons.</td>
                        </tr>
                        <tr>
                            <td><strong>interaction_effects</strong></td>
                            <td>Not specifically reported beyond adjustment for sex, age, year, and pack-years; score effect persisted after adjustment.</td>
                        </tr>
                        <tr>
                            <td><strong>key_finding</strong></td>
                            <td>A multi-SNP genotype score combining variants in DNA repair and cell-cycle genes stratified smokers over a >3-fold range of lung cancer risk, demonstrating the cumulative genetic contribution to differential susceptibility among smokers.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Genetic variability in DNA repair and cell cycle control pathway genes and risk of smoking‐related lung cancer', 'publication_date_yy_mm': '2012-10'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e74.6">
                <h3 class="extraction-instance">Extracted Data Instance 6 (e74.6)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of factors that explain why some smokers develop lung cancer while others do not, including genetic factors, exposure characteristics, environmental co-factors, protective factors, and mechanistic explanations for differential susceptibility.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Exposure_pack-years</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Cumulative smoking exposure (pack-years)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Smoking exposure quantified as pack-years (cumulative cigarette dose) and used as a primary exposure and covariate; cases were over-represented in higher pack-year categories compared with controls.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Genetic variability in DNA repair and cell cycle control pathway genes and risk of smoking-related lung cancer</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>study_type</strong></td>
                            <td>case-control study</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>White current and ex-cigarette smokers (722 cases, 929 controls), all with ≥10 pack-year exposure; pack-year categories used: <35, 35–49, 50–74, 75+.</td>
                        </tr>
                        <tr>
                            <td><strong>genetic_factor</strong></td>
                            <td>Not applicable</td>
                        </tr>
                        <tr>
                            <td><strong>genetic_factor_description</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>genetic_risk_estimate</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>smoking_exposure_measure</strong></td>
                            <td>Pack-years (cumulative cigarette exposure), categorized as <35, 35–49, 50–74, 75+; used in adjusted logistic models.</td>
                        </tr>
                        <tr>
                            <td><strong>dose_response_relationship</strong></td>
                            <td>Descriptive evidence: higher proportion of cases in the highest pack-year category (75+) compared with controls (cases 25.9% vs controls 13.5%), consistent with greater cumulative exposure increasing risk, but formal dose-response slope not provided.</td>
                        </tr>
                        <tr>
                            <td><strong>percentage_smokers_develop_cancer</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>metabolic_factor</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>dna_repair_factor</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>immune_inflammatory_factor</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>environmental_cofactor</strong></td>
                            <td>Cigarette smoking is the primary environmental exposure analyzed; paper emphasizes that genetic effects are assessed among smokers only.</td>
                        </tr>
                        <tr>
                            <td><strong>protective_factor</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>protective_factor_effect</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>mechanistic_explanation</strong></td>
                            <td>Greater cumulative exposure increases burden of DNA damage (bulky adducts and oxidative lesions) that must be repaired by NER/BER; individuals with impaired repair accumulate more mutations with higher dose.</td>
                        </tr>
                        <tr>
                            <td><strong>cancer_subtype</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>interaction_effects</strong></td>
                            <td>Analyses stratified by pack-year did not identify meaningful modification of SNP-lung cancer associations in this study (beyond prior literature suggestions for XRCC1 Trp194 in heavy smokers).</td>
                        </tr>
                        <tr>
                            <td><strong>key_finding</strong></td>
                            <td>Pack-year cumulative exposure is the key quantified environmental factor in this study and larger cumulative exposure is associated with higher lung cancer occurrence; genetic susceptibility modifies individual response to this damage burden.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Genetic variability in DNA repair and cell cycle control pathway genes and risk of smoking‐related lung cancer', 'publication_date_yy_mm': '2012-10'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e74.7">
                <h3 class="extraction-instance">Extracted Data Instance 7 (e74.7)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of factors that explain why some smokers develop lung cancer while others do not, including genetic factors, exposure characteristics, environmental co-factors, protective factors, and mechanistic explanations for differential susceptibility.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Mechanistic_framework</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Mechanistic explanations: NER vs BER and cell-cycle control</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Paper articulates a mechanistic framework: NER repairs bulky PAH adducts (e.g., benzo(a)pyrene), BER repairs oxidative lesions from cigarette smoke, and cell-cycle checkpoint genes (p53, p21, cyclins) govern damage-induced arrest/apoptosis; variants in these systems alter mutation accumulation and cancer risk.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Genetic variability in DNA repair and cell cycle control pathway genes and risk of smoking-related lung cancer</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>study_type</strong></td>
                            <td>mechanistic explanation within a case-control genetic association study</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>White current and ex-cigarette smokers (722 cases, 929 controls), aged 45–85.</td>
                        </tr>
                        <tr>
                            <td><strong>genetic_factor</strong></td>
                            <td>NER genes (ERCC family, GTF2H4, XPA, XPC etc.), BER genes (PARP1, XRCC1, OGG1, APEX1), cell-cycle genes (TP53, CDKN1A/p21, CCND1/cyclin D1, CCNE1/cyclin E).</td>
                        </tr>
                        <tr>
                            <td><strong>genetic_factor_description</strong></td>
                            <td>NER handles helix-distorting adducts caused by tobacco PAHs; BER removes oxidized bases from reactive oxygen species produced by smoking; cell-cycle proteins decide whether a damaged cell undergoes repair, arrest, or apoptosis.</td>
                        </tr>
                        <tr>
                            <td><strong>genetic_risk_estimate</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>smoking_exposure_measure</strong></td>
                            <td>Pack-years (categorized).</td>
                        </tr>
                        <tr>
                            <td><strong>dose_response_relationship</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>percentage_smokers_develop_cancer</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>metabolic_factor</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>dna_repair_factor</strong></td>
                            <td>Direct — differential efficiency of NER and BER explains differences in handling tobacco-induced lesions; compromised repair increases mutation fixation risk.</td>
                        </tr>
                        <tr>
                            <td><strong>immune_inflammatory_factor</strong></td>
                            <td>Apoptosis and inflammation mentioned as downstream or interacting processes (cell-cycle control and apoptosis mediate DNA damage responses), but no direct inflammatory biomarkers studied.</td>
                        </tr>
                        <tr>
                            <td><strong>environmental_cofactor</strong></td>
                            <td>Cigarette smoke (PAHs, ROS) provides the DNA damaging agents that interact with genetic repair capacity.</td>
                        </tr>
                        <tr>
                            <td><strong>protective_factor</strong></td>
                            <td>Variants that preserve efficient repair or promote effective checkpoint-mediated apoptosis are protective.</td>
                        </tr>
                        <tr>
                            <td><strong>protective_factor_effect</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>mechanistic_explanation</strong></td>
                            <td>Smoking generates both bulky adducts (repaired by NER) and oxidative lesions (repaired by BER); if genetic variants reduce the rate or fidelity of these repair pathways or impair cell-cycle arrest/apoptosis (mediated by p53, p21, cyclins), damaged DNA persists and leads to carcinogenic mutations. PARP1 and XRCC1 coordinate BER; LIG1 completes repair; TFIIH/XPB open DNA for NER; functional changes in these proteins therefore mediate differential susceptibility.</td>
                        </tr>
                        <tr>
                            <td><strong>cancer_subtype</strong></td>
                            <td>Mechanism applies broadly but may influence subtype distributions (e.g., certain LIG1 or PARP1 variants more frequent in adenocarcinoma vs squamous).</td>
                        </tr>
                        <tr>
                            <td><strong>interaction_effects</strong></td>
                            <td>Paper posits gene x environment interactions (genetic susceptibility reveals effects in presence of smoking) though only limited interactions were statistically observed in this dataset.</td>
                        </tr>
                        <tr>
                            <td><strong>key_finding</strong></td>
                            <td>A biologically coherent mechanism links tobacco-induced lesion types (PAH adducts, oxidative damage) to specific repair pathways (NER, BER) and cell-cycle control; inherited variation in these pathways can explain why some smokers accrue mutations and develop lung cancer while others do not.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Genetic variability in DNA repair and cell cycle control pathway genes and risk of smoking‐related lung cancer', 'publication_date_yy_mm': '2012-10'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e74.8">
                <h3 class="extraction-instance">Extracted Data Instance 8 (e74.8)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of factors that explain why some smokers develop lung cancer while others do not, including genetic factors, exposure characteristics, environmental co-factors, protective factors, and mechanistic explanations for differential susceptibility.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Subtype_and_interactions</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Tumor-subtype differences and limited gene-environment interactions</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Some SNPs showed differing frequencies between adenocarcinoma and squamous cell carcinoma cases; overall, the study found limited statistically significant gene-environment interactions beyond one sex-specific effect.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Genetic variability in DNA repair and cell cycle control pathway genes and risk of smoking-related lung cancer</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>study_type</strong></td>
                            <td>case-case comparisons within case-control study</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>258 squamous cell carcinoma cases and 301 adenocarcinoma cases compared (subset of the 722 cases), white smokers.</td>
                        </tr>
                        <tr>
                            <td><strong>genetic_factor</strong></td>
                            <td>PARP1 rs2048424, LIG1 rs10500298 (and others evaluated for subtype differences).</td>
                        </tr>
                        <tr>
                            <td><strong>genetic_factor_description</strong></td>
                            <td>Frequencies of certain variants differ by tumor histology, indicating potential histology-specific genetic susceptibility.</td>
                        </tr>
                        <tr>
                            <td><strong>genetic_risk_estimate</strong></td>
                            <td>PARP1 rs2048424 minor allele homozygotes more common in adenocarcinoma than squamous (12.0% vs 7.0%, P=0.049); LIG1 rs10500298 homozygotes adenocarcinoma 28.0% vs squamous 19.9% (P=0.027).</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_exposure_measure</strong></td>
                            <td>Pack-years used as covariate; histology comparisons internal to cases.</td>
                        </tr>
                        <tr>
                            <td><strong>dose_response_relationship</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>percentage_smokers_develop_cancer</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>metabolic_factor</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>dna_repair_factor</strong></td>
                            <td>Yes — subtype differences observed for repair gene variants (PARP1, LIG1).</td>
                        </tr>
                        <tr>
                            <td><strong>immune_inflammatory_factor</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>environmental_cofactor</strong></td>
                            <td>Analyses limited to smokers; no additional environmental cofactor data used to explain subtype differences.</td>
                        </tr>
                        <tr>
                            <td><strong>protective_factor</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>protective_factor_effect</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>mechanistic_explanation</strong></td>
                            <td>Different repair pathway deficits or variant combinations may predispose to distinct histologic pathways of tumorigenesis (adenocarcinoma vs squamous), reflecting tissue-specific consequences of particular DNA-damage/repair dynamics.</td>
                        </tr>
                        <tr>
                            <td><strong>cancer_subtype</strong></td>
                            <td>Adenocarcinoma and squamous cell carcinoma (non-small cell lung cancer subtypes); comparisons performed.</td>
                        </tr>
                        <tr>
                            <td><strong>interaction_effects</strong></td>
                            <td>Sex interaction: RPA3 rs7783714 homozygotes reduced risk among women (OR=0.41) but not men (OR=0.91), P_interaction=0.04. Otherwise limited evidence of gene x pack-year or other interactions.</td>
                        </tr>
                        <tr>
                            <td><strong>key_finding</strong></td>
                            <td>Certain repair-gene variants differ in frequency between adenocarcinoma and squamous cell carcinoma, suggesting histology-specific genetic susceptibility; otherwise, gene-environment interactions were minimal in this dataset aside from a sex-specific RPA3 effect.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Genetic variability in DNA repair and cell cycle control pathway genes and risk of smoking‐related lung cancer', 'publication_date_yy_mm': '2012-10'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </div>

        <div class="section">
            <h2>Potentially Relevant New Papers (mentioned by this paper)</h2>
            <ol>
                <li>International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways <em>(Rating: 2)</em></li>
                <li>A large-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter study <em>(Rating: 2)</em></li>
                <li>A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility <em>(Rating: 2)</em></li>
                <li>Poly(ADP-ribose) polymerase inhibition: PARP1 and beyond <em>(Rating: 1)</em></li>
                <li>A gene-based risk score for lung cancer susceptibility in smokers and ex-smokers <em>(Rating: 1)</em></li>
            </ol>
        </div>

        </div>

    </div>
</body>
</html>